MVM CLOSES MVM IV
MVM Life Science Partners LLP has announced the closing of a $233 million healthcare fund, MVM IV. The fund is MVM’s fourth and largest raised to date.
Read moreBIOTHERANOSTICS INC. CLOSES $32 MILLION FINANCING
bioTheranostics, Inc., a leader in molecular diagnostics for cancer, has announced that it has closed a $32 million financing led by MVM Life Science Partners
Read more
MVM Overview
- • Venture capital and growth equity investor in healthcare companies since 1997
- • More than $700 million under management across several funds
- • Investment teams in Boston and London provide global perspective and coverage
- • Partners of MVM have more than 80 years of healthcare investment experience
Recent News
MVM Life Science Partners LLP closes MVM IV
MVM Life Science Partners LLP announces the closing of a $233 million healthcare fund, MVM IV.
Heptares and Allergan Announce Global R&D and Commercialization Partnership
Heptares and Allergan Announce Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer's and Other Neurological Disorders